TRULIEVE CANNABIS CORP - stock earnings
TCNNF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -33.4 million USD | 287.0 million USD |
| 2023Q3 | -25.4 million USD | 275.2 million USD |
| 2023Q2 | -403.8 million USD | 281.8 million USD |
| 2023Q1 | -64.1 million USD | 289.1 million USD |
| 2022Q4 | -77.0 million USD | 302.2 million USD |
| 2022Q3 | -114.6 million USD | 300.8 million USD |
| 2022Q2 | -22.5 million USD | 320.3 million USD |
| 2022Q1 | -32.0 million USD | 318.3 million USD |
| 2021Q4 | -71.5 million USD | 305.3 million USD |
| 2021Q3 | 18.6 million USD | 224.1 million USD |
| 2021Q2 | 40.9 million USD | 215.1 million USD |
| 2021Q1 | 30.1 million USD | 193.8 million USD |
| 2020Q4 | 37.7 million USD | 168.4 million USD |
| 2020Q3 | 4.7 million USD | 136.3 million USD |
| 2020Q2 | 6.6 million USD | 120.8 million USD |
| 2020Q1 | 14.0 million USD | 96.1 million USD |
| 2019Q4 | 45.5 million USD | 79.7 million USD |
| 2019Q3 | 60.3 million USD | 70.7 million USD |
| 2019Q2 | 57.5 million USD | 57.9 million USD |
| 2019Q1 | 14.7 million USD | 44.5 million USD |
| 2018Q4 | 10.7 million USD | 35.9 million USD |
| 2018Q3 | 17.5 million USD | 28.3 million USD |
| 2018Q2 | 7.9 million USD | 23.3 million USD |
| 2018Q1 | 7.4 million USD | 19.3 million USD |
| 2017Q4 | 400247 USD | 8.3 million USD |
| 2017Q3 | 462234 USD | 3.4 million USD |
TCNNF Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -526.8 million USD | 1.1 billion USD |
| 2022 | -246.1 million USD | 1.2 billion USD |
| 2021 | 18.0 million USD | 938.4 million USD |
| 2020 | 63.0 million USD | 521.5 million USD |
| 2019 | 178.0 million USD | 252.8 million USD |
| 2018 | 43.0 million USD | 102.8 million USD |
| 2017 | -36352 USD | 19.8 million USD |
| 2016 | -7325 USD | ? USD |
TCNNF
Price: $12.40
52 week price:
Earnings Per Share: -2.28 USD
P/E Ratio: -3.46
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 1.4 million
Market Capitalization: 2.1 billion